A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia. (nejm.org)

Authors: Kuter DJ … Patwari P Journal: New England Journal of Medicine Published: 2026-04-09 DOI: https://doi.org/10.1056/NEJMoa2513120